Literature DB >> 9740145

Needle biopsies of the prostate: what constitutes adequate histologic sampling?

R B Lane1, C G Lane, K A Mangold, M H Johnson, W C Allsbrook.   

Abstract

OBJECTIVE: The automated biopsy gun and increased screening for adenocarcinoma of the prostate have led to increased numbers of biopsies with only tiny foci of prostatic carcinoma. Consequently, the risk of failing to sample a small focus of carcinoma histologically has increased as well. Most pathologists routinely sample prostatic needle biopsies at more than 1 level. An expert panel has recently suggested that prostatic needle biopsies be sampled at at least 2 levels. However, there have been no studies measuring the amount of additional tissue sampled by multiple levels versus 1 level.
METHODS: Forty-two prostatic needle biopsies were serially sectioned at 4-microm levels. Hematoxylin-eosin-stained slides were prepared from every fifth section. The total length of each biopsy was compared with the length sampled by 1 level (50% through the block) and 3 levels (25%, 50%, and 75% through the block).
RESULTS: Sampling the tissue at 1 level missed an average of 23.4% of the total biopsy length. Sampling the tissue at 3 levels significantly improved this average to 7% (P = .0001).
CONCLUSIONS: This study shows that a single histologic section of a prostatic needle biopsy often fails to sample a significant portion of available tissue. This could occasionally result in failure to sample a small focus of prostatic carcinoma. The authors recommend that prostatic needle biopsies be routinely sampled at 3 levels (approximately 25%, 50%, and 75% through the block).

Entities:  

Mesh:

Year:  1998        PMID: 9740145

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  8 in total

1.  Variations in the processing of prostatic needle cores in the UK; what is safe?

Authors:  O Biedrzycki; M Varma; D M Berney
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

2.  Diagnostic yield of touch imprint cytology of prostate core needle biopsies.

Authors:  Sebastian Mannweiler; Karl Pummer; Marco Auprich; Günter Galle; Gábor Méhes; Manfred Ratschek; Oleksiy Tsybrovskyy; Farid Moinfar
Journal:  Pathol Oncol Res       Date:  2008-10-29       Impact factor: 3.201

3.  Negative colorectal polyp biopsies: the utility of cutting deeper levels.

Authors:  Brian A Schick; Carolyn A McLean; David K Driman
Journal:  Virchows Arch       Date:  2015-10-16       Impact factor: 4.064

4.  Does length of prostate biopsy cores have an impact on diagnosis of prostate cancer?

Authors:  Müslüm Ergün; Ekrem İslamoğlu; Soner Yalçınkaya; Hüsnü Tokgöz; Murat Savaş
Journal:  Turk J Urol       Date:  2016-09

Review 5.  Guidelines for processing and reporting of prostatic needle biopsies.

Authors:  Th H van der Kwast; C Lopes; C Santonja; C-G Pihl; I Neetens; P Martikainen; S Di Lollo; L Bubendorf; R F Hoedemaeker
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

Review 6.  Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.

Authors:  Marc A Bjurlin; H Ballentine Carter; Paul Schellhammer; Michael S Cookson; Leonard G Gomella; Dean Troyer; Thomas M Wheeler; Steven Schlossberg; David F Penson; Samir S Taneja
Journal:  J Urol       Date:  2013-02-26       Impact factor: 7.450

7.  Guidelines on processing and reporting of prostate biopsies: the 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Authors:  T Van der Kwast; L Bubendorf; C Mazerolles; M R Raspollini; G J Van Leenders; C-G Pihl; P Kujala
Journal:  Virchows Arch       Date:  2013-08-06       Impact factor: 4.064

8.  Touch imprint cytology of prostate core needle biopsy specimens: A useful method for immediate reporting of prostate cancer.

Authors:  Berna Aytac; Fatma Oz Atalay; Hakan Vuruskan; Gulaydan Filiz
Journal:  J Cytol       Date:  2012-07       Impact factor: 1.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.